Rexulti (Brexpiprazole) for Alzheimer's

Overview
Rexulti is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat agitation due to dementia associated with Alzheimer’s disease. Rexulti is also referred to by its drug name brexpiprazole.

Rexulti is an atypical antipsychotic. It is believed to work by addressing the imbalance of certain neurotransmitters in the brain.

How do I take it?
Prescribing information states that Rexulti is taken orally once a day. Rexulti comes in tablet form.

Side effects
The FDA-approved label for Rexulti lists common side effects including the common cold and dizziness.

Rare but serious side effects listed for Rexulti include stroke and neuroleptic malignant syndrome.

For more details about this treatment, visit:

Rexulti — Otsuka/Lundbeck
https://www.rexulti.com/aad